Text and Data Mining valid from 2016-09-15
Received: 20 May 2016
Accepted: 31 August 2016
First Online: 15 September 2016
: Drs Levin and Buck report owning equity interest in CEP Biotech which has licensed commercialization of a panel of monoclonal antibodies directed against sAC. All other author(s) declare no competing financial interests.